Philadelphia 76ers · — · #—
—
| Period | GP | MIN | PTS | REB | AST | PRA | STL | BLK | TOV | 2PM | 2PA | 2P% | 3PM | 3PA | 3P% | FTM | FTA | FT% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Last 3 | 3 | 26.3 | 13.0 | 4.7 | 1.7 | 19.3 | 0.7 | 0.0 | 2.0 | 3.7 | 5.3 |
| 68.8% |
| 1.3 |
| 6.0 |
| 22.2% |
| 1.7 |
| 2.3 |
| 71.4% |
| Last 5 | 5 | 29.1 | 15.0 | 4.6 | 2.6 | 22.2 | 1.2 | 0.0 | 2.0 | 3.2 | 7.0 | 45.7% | 2.2 | 5.6 | 39.3% | 2.0 | 3.0 | 66.7% |
| Last 10 | 10 | 31.1 | 21.0 | 5.7 | 3.3 | 30.0 | 2.2 | 0.3 | 2.0 | 4.1 | 7.7 | 53.2% | 3.4 | 8.2 | 41.5% | 2.6 | 3.5 | 74.3% |
| Last 20 | 20 | 31.8 | 18.6 | 5.2 | 3.8 | 27.5 | 2.0 | 0.4 | 1.5 | 3.9 | 7.4 | 53.4% | 2.9 | 7.3 | 38.8% | 2.1 | 2.8 | 76.4% |
| Season | 37 | 30.7 | 17.3 | 5.3 | 3.6 | 26.2 | 1.7 | 0.4 | 1.7 | 3.4 | 7.0 | 48.4% | 2.7 | 6.9 | 39.2% | 2.5 | 3.0 | 82.0% |
high usage, high on-ball creation, high assist rate, low rim finishing off the ball
2025-26 season · fitted over 2022-23–2025-26
Style profile over 446 qualified players (8+ games, 10+ min/game). 100% is an identical profile; 50% is unrelated.
| Date | Matchup | W/L | MIN | PTS | REB | AST | STL | BLK | TOV | FGM | FGA | FG% | 3PM | 3PA | 3P% | FTM | FTA | FT% | +/- |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-12 | PHI vs. MIL | W | 21.3 | 11 | 5 | 2 | 0 | 0 | 1 | 4 | 7 | 57.1% | 1 | 4 | 25.0% | 2 | 2 | 100.0% | 2.0 |
| 2026-04-10 | PHI @ IND | W | 33.5 | 21 | 5 | 2 | 1 | 0 | 1 | 9 | 19 | 47.4% | 3 | 9 | 33.3% | 0 | 1 | 0.0% | 7.0 |
| 2026-04-09 | PHI @ HOU | L | 24.1 | 7 | 4 | 1 | 1 | 0 | 4 | 2 | 8 | 25.0% | 0 | 5 | 0.0% | 3 | 4 | 75.0% | -15.0 |
| 2026-04-06 | PHI @ SAS | L | 38.1 | 16 | 4 | 4 | 2 | 0 | 1 | 5 | 15 | 33.3% | 4 | 5 | 80.0% | 2 | 4 | 50.0% | -6.0 |
| 2026-04-04 | PHI vs. DET | L | 28.3 | 20 | 5 | 4 | 2 | 0 | 3 | 7 | 14 | 50.0% | 3 | 5 | 60.0% | 3 | 4 | 75.0% | -9.0 |
| 2026-04-03 | PHI vs. MIN | W | 38.0 | 23 | 6 | 6 | 4 | 1 | 6 | 6 | 15 | 40.0% | 3 | 7 | 42.9% | 8 | 10 | 80.0% | 0.0 |
| 2026-04-01 | PHI @ WAS | W | 30.4 | 39 | 5 | 6 | 3 | 0 | 0 | 15 | 22 | 68.2% | 6 | 12 | 50.0% | 3 | 4 | 75.0% | 26.0 |
| 2026-03-30 | PHI @ MIA | L | 34.7 | 19 | 4 | 2 | 1 | 0 | 1 | 7 | 18 | 38.9% | 4 | 11 | 36.4% | 1 | 1 | 100.0% | -22.0 |
| 2026-03-28 | PHI @ CHA | W | 36.4 | 26 | 13 | 2 | 4 | 1 | 3 | 9 | 19 | 47.4% | 4 | 11 | 36.4% | 4 | 5 | 80.0% | -5.0 |
| 2026-03-25 | PHI vs. CHI | W | 26.3 | 28 | 6 | 4 | 4 | 1 | 0 | 11 | 22 | 50.0% | 6 | 13 | 46.2% | 0 | 0 | 0.0% | 14.0 |
| 2026-01-29 | PHI vs. SAC | W | 36.1 | 15 | 2 | 5 | 2 | 0 | 1 | 7 | 15 | 46.7% | 1 | 4 | 25.0% | 0 | 0 | 0.0% | 5.0 |
| 2026-01-27 | PHI vs. MIL | W | 33.0 | 32 | 5 | 5 | 2 | 0 | 1 | 11 | 21 | 52.4% | 9 | 15 | 60.0% | 1 | 2 | 50.0% | 13.0 |
| 2026-01-24 | PHI vs. NYK | L | 32.3 | 9 | 6 | 2 | 2 | 0 | 1 | 3 | 10 | 30.0% | 0 | 3 | 0.0% | 3 | 3 | 100.0% | -2.0 |
| 2026-01-22 | PHI vs. HOU | W | 36.5 | 10 | 6 | 4 | 3 | 1 | 1 | 4 | 9 | 44.4% | 2 | 5 | 40.0% | 0 | 0 | 0.0% | -1.0 |
| 2026-01-16 | PHI vs. CLE | L | 30.3 | 14 | 4 | 5 | 2 | 0 | 1 | 6 | 12 | 50.0% | 2 | 6 | 33.3% | 0 | 0 | 0.0% | 9.0 |
| 2026-01-14 | PHI vs. CLE | L | 29.7 | 17 | 4 | 4 | 1 | 0 | 0 | 7 | 14 | 50.0% | 2 | 4 | 50.0% | 1 | 2 | 50.0% | -8.0 |
| 2026-01-12 | PHI @ TOR | W | 28.6 | 15 | 4 | 6 | 0 | 0 | 1 | 5 | 13 | 38.5% | 1 | 6 | 16.7% | 4 | 5 | 80.0% | 4.0 |
| 2026-01-09 | PHI @ ORL | W | 33.2 | 18 | 9 | 3 | 3 | 2 | 3 | 8 | 21 | 38.1% | 0 | 7 | 0.0% | 2 | 2 | 100.0% | 9.0 |
| 2026-01-07 | PHI vs. WAS | W | 32.9 | 23 | 4 | 5 | 2 | 1 | 1 | 7 | 11 | 63.6% | 4 | 8 | 50.0% | 5 | 6 | 83.3% | 25.0 |
| 2026-01-05 | PHI vs. DEN | L | 32.3 | 8 | 2 | 3 | 2 | 1 | 0 | 3 | 10 | 30.0% | 2 | 7 | 28.6% | 0 | 0 | 0.0% | -18.0 |
| 2026-01-03 | PHI @ NYK | W | 35.2 | 15 | 8 | 6 | 0 | 2 | 1 | 5 | 11 | 45.5% | 3 | 5 | 60.0% | 2 | 3 | 66.7% | 5.0 |
| 2026-01-01 | PHI @ DAL | W | 33.1 | 14 | 7 | 2 | 1 | 0 | 5 | 5 | 11 | 45.5% | 0 | 3 | 0.0% | 4 | 4 | 100.0% | 20.0 |
| 2025-12-30 | PHI @ MEM | W | 39.1 | 17 | 3 | 3 | 0 | 0 | 3 | 6 | 17 | 35.3% | 3 | 11 | 27.3% | 2 | 2 | 100.0% | 11.0 |
| 2025-12-28 | PHI @ OKC | L | 29.2 | 12 | 4 | 3 | 1 | 0 | 3 | 4 | 11 | 36.4% | 4 | 7 | 57.1% | 0 | 0 | 0.0% | -19.0 |
| 2025-12-26 | PHI @ CHI | L | 34.5 | 15 | 11 | 5 | 0 | 0 | 1 | 5 | 15 | 33.3% | 4 | 9 | 44.4% | 1 | 1 | 100.0% | -1.0 |
| 2025-12-23 | PHI vs. BKN | L | 33.1 | 19 | 4 | 2 | 4 | 2 | 3 | 5 | 14 | 35.7% | 2 | 7 | 28.6% | 7 | 8 | 87.5% | 0.0 |
| 2025-12-19 | PHI @ NYK | W | 33.1 | 7 | 6 | 4 | 1 | 0 | 1 | 2 | 10 | 20.0% | 1 | 6 | 16.7% | 2 | 2 | 100.0% | 16.0 |
| 2025-12-14 | PHI @ ATL | L | 33.4 | 35 | 4 | 3 | 0 | 1 | 2 | 11 | 21 | 52.4% | 7 | 10 | 70.0% | 6 | 6 | 100.0% | 2.0 |
| 2025-12-12 | PHI vs. IND | W | 33.1 | 23 | 6 | 5 | 1 | 0 | 4 | 8 | 17 | 47.1% | 4 | 7 | 57.1% | 3 | 3 | 100.0% | 19.0 |
| 2025-12-07 | PHI vs. LAL | L | 32.1 | 12 | 6 | 3 | 1 | 0 | 1 | 3 | 8 | 37.5% | 1 | 3 | 33.3% | 5 | 5 | 100.0% | -12.0 |
| 2025-12-05 | PHI @ MIL | W | 30.0 | 20 | 5 | 5 | 1 | 0 | 0 | 7 | 15 | 46.7% | 2 | 6 | 33.3% | 4 | 4 | 100.0% | 7.0 |
| 2025-12-02 | PHI vs. WAS | W | 17.7 | 11 | 5 | 0 | 1 | 0 | 2 | 4 | 10 | 40.0% | 3 | 5 | 60.0% | 0 | 0 | 0.0% | 6.0 |
| 2025-11-30 | PHI vs. ATL | L | 28.0 | 16 | 7 | 4 | 5 | 0 | 1 | 6 | 17 | 35.3% | 2 | 8 | 25.0% | 2 | 2 | 100.0% | 1.0 |
| 2025-11-28 | PHI @ BKN | W | 21.4 | 14 | 3 | 2 | 2 | 0 | 1 | 6 | 10 | 60.0% | 2 | 5 | 40.0% | 0 | 0 | 0.0% | 9.0 |
| 2025-11-23 | PHI vs. MIA | L | 20.2 | 10 | 2 | 5 | 1 | 1 | 2 | 3 | 10 | 30.0% | 0 | 5 | 0.0% | 4 | 5 | 80.0% | 3.0 |
| 2025-11-20 | PHI @ MIL | W | 24.7 | 21 | 5 | 3 | 2 | 0 | 3 | 7 | 12 | 58.3% | 4 | 7 | 57.1% | 3 | 4 | 75.0% | 3.0 |
| 2025-11-17 | PHI vs. LAC | W | 21.1 | 9 | 7 | 3 | 0 | 2 | 1 | 2 | 9 | 22.2% | 1 | 4 | 25.0% | 4 | 7 | 57.1% | -9.0 |